![](https://medfyle.com/articles/15-retrospective-review-of-the-use-of-anti-cgrp-monoclonal-antibodies-to-treat-headaches-in-patients-with-idiopathic-intracranial-hypertension/download_file?filename=articles%2F158_libraryimage.jpg)
![](https://medfyle.com/files/organizations/AHS.png)
Retrospective Review of the Use of Anti-CGRP Monoclonal Antibodies to Treat Headaches in Patients with Idiopathic Intracranial Hypertension
In this medfyle
Expert commentary by Deborah I. Friedman, MD, MPH, FAAN, FAHS
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Acknowledgements
This is a highlights summary of an oral session given at the AHSAM 2020 Virtual Annual Scientific Meeting and presented by:
Lindsay Frerichs, MD
UT Southwestern Dallas, Texas
The content is produced by Infomedica, the official reporting partner of ASHAM 2020 Virtual Annual Scientific Meeting. The summary text was drafted by Goldcrest Medical Writing, reviewed by Marco Vercellino, MD, an independent external expert, and approved by Jessica Ailani, MD, FAHS and Mark J. Burish, MD, PhD, the scientific editors of the program.
The presenting authors of the original session had no part in the creation of this conference highlights summary.
In addition, an expert commentary on the topic has been provided by:
Deborah I. Friedman, MD, MPH, FAAN, FAHS
University of Texas Southwestern Medical Center, Dallas, Texas, USA
About the Expert
Deborah I. Friedman, MD, MPH, FAAN, FAHS
University of Texas Southwestern Medical Center, Dallas, Texas, USA
Dr. Friedman is Professor of Neurology & Neurotherapeutics and Ophthalmology at University of Texas Southwestern Medical Center, where she directs the Headache and Facial Pain Program and Cerebrospinal Fluid Dynamics Program. She is Board Certified in Neurology and Headache Medicine, and is a Fellow of the American Academy of Neurology, American Headache Society, American Neurological Association and the North American Neuro-Ophthalmology Society (NANOS). She served on the Board of Directors of AHS and is a Past-President of NANOS. She has published over 100 articles in peer-reviewed journals and 22 book chapters. Her key interests are intracranial pressure disorders, cluster headache and migraine.
References
1. Wall M, Kupersmith MJ, Kieburtz KD, et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 2014;71:693-701.
2. Friedman DI, Rausch EA. Headache diagnoses in patients with treated idiopathic intracranial hypertension. Neurology 2002;58:1551-1553.
3. Friedman DI, Quiros PA, Subramanian PS, et al. Headache in Idiopathic Intracranial Hypertension: Findings From the Idiopathic Intracranial Hypertension Treatment Trial. Headache 2017;57:1195-1205.